275 related articles for article (PubMed ID: 8671718)
21. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
Shane BS; Lockhart AM; Winston GW; Tindall KR
Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
[TBL] [Abstract][Full Text] [Related]
22. Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis.
Provost GS; Mirsalis JC; Rogers BJ; Short JM
Environ Mol Mutagen; 1996; 28(4):342-7. PubMed ID: 8991062
[TBL] [Abstract][Full Text] [Related]
23. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice.
Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML
Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479
[TBL] [Abstract][Full Text] [Related]
24. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
You YH; Halangoda A; Buettner V; Hill K; Sommer S; Pfeifer G
Mutat Res; 1998 Dec; 420(1-3):55-65. PubMed ID: 9838042
[TBL] [Abstract][Full Text] [Related]
25. Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver.
Ross JA; Leavitt SA
Mutagenesis; 1998 Mar; 13(2):173-9. PubMed ID: 9568591
[TBL] [Abstract][Full Text] [Related]
26. A novel lacI transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse.
Andrew SE; Pownall S; Fox J; Hsiao L; Hambleton J; Penney JE; Kohler SW; Jirik FR
Mutat Res; 1996 Oct; 357(1-2):57-66. PubMed ID: 8876680
[TBL] [Abstract][Full Text] [Related]
27. Trans-4-hydroxy-2-nonenal, an aldehydic lipid peroxidation product, lacks genotoxicity in lacI transgenic mice.
Nishikawa A; Furukawa F; Kasahara K; Ikezaki S; Itoh T; Suzuki T; Uchida K; Kurihara M; Hayashi M; Miyata N; Hirose M
Cancer Lett; 2000 Jan; 148(1):81-6. PubMed ID: 10680596
[TBL] [Abstract][Full Text] [Related]
28. Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene.
Saranko CJ; Meyer KG; Pluta LJ; Henderson RF; Recio L
Mutat Res; 2001 Jan; 473(1):37-49. PubMed ID: 11166025
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous mutation spectrum at the lambda cII locus in liver, lung, and spleen tissue of Big Blue transgenic mice.
Harbach PR; Zimmer DM; Filipunas AL; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(2):132-43. PubMed ID: 10217067
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
[TBL] [Abstract][Full Text] [Related]
31. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
Knöll A; Jacobson DP; Nishino H; Kretz PL; Short JM; Sommer SS
Mutat Res; 1996 Jun; 352(1-2):9-22. PubMed ID: 8676922
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
[TBL] [Abstract][Full Text] [Related]
33. Genotoxicity of agaritine in the lacI transgenic mouse mutation assay: evaluation of the health risk of mushroom consumption.
Shephard SE; Gunz D; Schlatter C
Food Chem Toxicol; 1995 Apr; 33(4):257-64. PubMed ID: 7737599
[TBL] [Abstract][Full Text] [Related]
34. Mutational specificity of aflatoxin B1. Comparison of in vivo host-mediated assay with in vitro S9 metabolic activation.
Prieto-Alamo MJ; Jurado J; Abril N; Díaz-Pohl C; Bolcsfoldi G; Pueyo C
Carcinogenesis; 1996 Sep; 17(9):1997-2002. PubMed ID: 8824526
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of spontaneous and chemical-induced lacI mutations in germ cells from lambda/lacI transgenic mice.
Putman DL; Ritter AP; Carr GJ; Young RR
Mutat Res; 1997 Feb; 388(2-3):137-43. PubMed ID: 9057874
[TBL] [Abstract][Full Text] [Related]
36. Plasmid rescue from transgenic mouse DNA using LacI repressor protein conjugated to magnetic beads.
Gossen JA; de Leeuw WJ; Molijn AC; Vijg J
Biotechniques; 1993 Apr; 14(4):624-9. PubMed ID: 8476606
[TBL] [Abstract][Full Text] [Related]
37. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver.
Leavitt SA; DeAngelo AB; George MH; Ross JA
Carcinogenesis; 1997 Nov; 18(11):2101-6. PubMed ID: 9395208
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of lacI mutation in germ cells and micronuclei in peripheral blood after treatment of male lacI transgenic mice with ethylnitrosourea, isopropylmethane sulfonate or methylmethane sulfonate.
Gorelick NJ; Andrews JL; Gibson DP; Carr GJ; Aardema MJ
Mutat Res; 1997 Feb; 388(2-3):187-95. PubMed ID: 9057880
[TBL] [Abstract][Full Text] [Related]
40. Mutation studies in lacI transgenic mice after exposure to radiation or cyclophosphamide.
Hoyes KP; Wadeson PJ; Sharma HL; Hendry JH; Morris ID
Mutagenesis; 1998 Nov; 13(6):607-12. PubMed ID: 9862192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
